A
SECTION A — HUMAN NECESSITIES
  
HEALTH; AMUSEMENT
 A61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
 A61P
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS  [7]
 A61P

Note(s)

  1. This subclass covers therapeutic activity of chemical compounds or medicinal preparations already classified as such in subclasses A61K or C12N, or in classes C01, C07 or C08[7]
  2. In this subclass, the term "drugs" includes chemical compounds or compositions with therapeutic activity. [7]
  3. In this subclass, therapeutic activity is classified in all appropriate places. [7]
  4. The classification symbols of this subclass are not listed first when assigned to patent documents. [7]
P:20 A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system  [7]
 A61P 1/02
·  Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis  [7]
 A61P 1/04
·  for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants  [7]
 A61P 1/06
·  Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia  [7]
 A61P 1/08
·  for nausea, cinetosis or vertigo; Antiemetics  [7]
 A61P 1/10
·  Laxatives  [7]
 A61P 1/12
·  Antidiarrhoeals  [7]
 A61P 1/14
·  Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents  [7]
 A61P 1/16
·  for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics  [7]
 A61P 1/18
·  for pancreatic disorders, e.g. pancreatic enzymes  [7]
P:40 A61P 3/00
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00)  [7]
 A61P 3/02
·  Nutrients, e.g. vitamins, minerals  [7]
 A61P 3/04
·  Anorexiants; Antiobesity agents  [7]
 A61P 3/06
·  Antihyperlipidemics  [7]
 A61P 3/08
·  for glucose homeostasis (pancreatic hormones A61P 5/48)  [7]
 A61P 3/10
·  ·  for hyperglycaemia, e.g. antidiabetics  [7]
 A61P 3/12
·  for electrolyte homeostasis  [7]
 A61P 3/14
·  ·  for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/10; bone metastasis A61P 35/04)  [7]
P:50 A61P 5/00
Drugs for disorders of the endocrine system  [7]
 A61P 5/02
·  of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin  [7]
 A61P 5/04
·  ·  for decreasing, blocking or antagonising the activity of the hypothalamic hormones  [7]
 A61P 5/06
·  of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH  [7]
 A61P 5/08
·  ·  for decreasing, blocking or antagonising the activity of the anterior pituitary hormones  [7]
 A61P 5/10
·  of the posterior pituitary hormones, e.g. oxytocin, ADH  [7]
 A61P 5/12
·  ·  for decreasing, blocking or antagonising the activity of the posterior pituitary hormones  [7]
 A61P 5/14
·  of the thyroid hormones, e.g. T3, T4  [7]
 A61P 5/16
·  ·  for decreasing, blocking or antagonising the activity of the thyroid hormones  [7]
 A61P 5/18
·  of the parathyroid hormones  [7]
 A61P 5/20
·  ·  for decreasing, blocking or antagonising the activity of PTH  [7]
 A61P 5/22
·  ·  for decreasing, blocking or antagonising the activity of calcitonin  [7]
 A61P 5/24
·  of the sex hormones  [7]
 A61P 5/26
·  ·  Androgens  [7]
 A61P 5/28
·  ·  Antiandrogens  [7]
 A61P 5/30
·  ·  Oestrogens  [7]
 A61P 5/32
·  ·  Antioestrogens  [7]
 A61P 5/34
·  ·  Gestagens  [7]
 A61P 5/36
·  ·  Antigestagens  [7]
 A61P 5/38
·  of the suprarenal hormones  [7]
 A61P 5/40
·  ·  Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids  [7]
 A61P 5/42
·  ·  for decreasing, blocking or antagonising the activity of mineralocorticosteroids  [7]
 A61P 5/44
·  ·  Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids  [7]
 A61P 5/46
·  ·  for decreasing, blocking or antagonising the activity of glucocorticosteroids  [7]
 A61P 5/48
·  of the pancreatic hormones  [7]
 A61P 5/50
·  ·  for increasing or potentiating the activity of insulin  [7]
P:30 A61P 7/00
Drugs for disorders of the blood or the extracellular fluid  [7]
 A61P 7/02
·  Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors  [7]
 A61P 7/04
·  Antihaemorrhagics; Procoagulants; Haemostatatic agents; Antifibrinolytic agents  [7]
 A61P 7/06
·  Antianaemics  [7]
 A61P 7/08
·  Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P 27/04)  [7]
 A61P 7/10
·  Antioedematous agents; Diuretics  [7]
 A61P 7/12
·  Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P 5/10)  [7]
P:60 A61P 9/00
Drugs for disorders of the cardiovascular system  [7]
 A61P 9/02
·  Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives  [7]
 A61P 9/04
·  Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure  [7]
 A61P 9/06
·  Antiarrhythmics  [7]
 A61P 9/08
·  Vasodilators for multiple indications  [7]
 A61P 9/10
·  for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis  [7]
 A61P 9/12
·  Antihypertensives  [7]
 A61P 9/14
·  Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers  [7]
P:70 A61P 11/00
Drugs for disorders of the respiratory system  [7]
 A61P 11/02
·  Nasal agents, e.g. decongestants  [7]
 A61P 11/04
·  for throat disorders  [7]
 A61P 11/06
·  Antiasthmatics  [7]
 A61P 11/08
·  Bronchodilators  [7]
 A61P 11/10
·  Expectorants  [7]
 A61P 11/12
·  Mucolytics  [7]
 A61P 11/14
·  Antitussive agents  [7]
 A61P 11/16
·  Central respiratory analeptics  [7]
P:80 A61P 13/00
Drugs for disorders of the urinary system (diuretics A61P 7/10)  [7]
 A61P 13/02
·  of urine or of the urinary tract, e.g. urine acidifiers  [7]
 A61P 13/04
·  for urolithiasis  [7]
 A61P 13/06
·  Anti-spasmodics  [7]
 A61P 13/08
·  of the prostate  [7]
 A61P 13/10
·  of the bladder  [7]
 A61P 13/12
·  of the kidneys  [7]
P:90 A61P 15/00
Drugs for genital or sexual disorders (for disorders of sex hormones A61P 5/24); Contraceptives  [7]
 A61P 15/02
·  for disorders of the vagina  [7]
 A61P 15/04
·  for inducing labour or abortion; Uterotonics  [7]
 A61P 15/06
·  Antiabortive agents; Labour repressants  [7]
 A61P 15/08
·  for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis  [7]
 A61P 15/10
·  for impotence  [7]
 A61P 15/12
·  for climacteric disorders  [7]
 A61P 15/14
·  for lactation disorders, e.g. galactorrhoea  [7]
 A61P 15/16
·  Masculine contraceptives  [7]
 A61P 15/18
·  Feminine contraceptives  [7]
P:100 A61P 17/00
Drugs for dermatological disorders  [7]
 A61P 17/02
·  for treating wounds, ulcers, burns, scars, keloids, or the like  [7]
 A61P 17/04
·  Antipruritics  [7]
 A61P 17/06
·  Antipsoriatics  [7]
 A61P 17/08
·  Antiseborrheics  [7]
 A61P 17/10
·  Anti-acne agents  [7]
 A61P 17/12
·  Keratolytics, e.g. wart or anti-corn preparations  [7]
 A61P 17/14
·  for baldness or alopecia  [7]
 A61P 17/16
·  Emollients or protectives, e.g. against radiation  [7]
 A61P 17/18
·  Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q 17/00)  [8]
P:110 A61P 19/00
Drugs for skeletal disorders  [7]
 A61P 19/02
·  for joint disorders, e.g. arthritis, arthrosis  [7]
 A61P 19/04
·  for non-specific disorders of the connective tissue  [7]
 A61P 19/06
·  Antigout agents, e.g. antihyperuricemic or uricosuric agents  [7]
 A61P 19/08
·  for bone diseases, e.g. rachitism, Paget's disease  [7]
 A61P 19/10
·  ·  for osteoporosis  [7]
P:120 A61P 21/00
Drugs for disorders of the muscular or neuromuscular system  [7]
 A61P 21/02
·  Muscle relaxants, e.g. for tetanus or cramps  [7]
 A61P 21/04
·  for myasthenia gravis  [7]
 A61P 21/06
·  Anabolic agents (androgens A61P 5/26)  [7]
P:0 A61P 23/00
Anaesthetics  [7]
 A61P 23/02
·  Local anaesthetics  [7]
P:130 A61P 25/00
Drugs for disorders of the nervous system  [7]
 A61P 25/02
·  for peripheral neuropathies  [7]
 A61P 25/04
·  Centrally acting analgesics, e.g. opioids  [7]
 A61P 25/06
·  Antimigraine agents  [7]
 A61P 25/08
·  Antiepileptics; Anticonvulsants  [7]
 A61P 25/10
·  ·  for petit-mal  [7]
 A61P 25/12
·  ·  for grand-mal  [7]
 A61P 25/14
·  for treating abnormal movements, e.g. chorea, dyskinesia  [7]
 A61P 25/16
·  ·  Anti-Parkinson drugs  [7]
 A61P 25/18
·  Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia  [7]
 A61P 25/20
·  Hypnotics; Sedatives  [7]
 A61P 25/22
·  Anxiolytics  [7]
 A61P 25/24
·  Antidepressants  [7]
 A61P 25/26
·  Psychostimulants, e.g. nicotine, cocaine  [7]
 A61P 25/28
·  for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia  [7]
 A61P 25/30
·  for treating abuse or dependence  [7]
 A61P 25/32
·  ·  Alcohol-abuse  [7]
 A61P 25/34
·  ·  Tobacco-abuse  [7]
 A61P 25/36
·  ·  Opioid-abuse  [7]
P:140 A61P 27/00
Drugs for disorders of the senses  [7]
 A61P 27/02
·  Ophthalmic agents  [7]
 A61P 27/04
·  ·  Artificial tears; Irrigation solutions  [7]
 A61P 27/06
·  ·  Antiglaucoma agents or miotics  [7]
 A61P 27/08
·  ·  Mydriatics or cycloplegics  [7]
 A61P 27/10
·  ·  for accommodation disorders, e.g. myopia  [7]
 A61P 27/12
·  ·  for cataracts  [7]
 A61P 27/14
·  ·  Decongestants or antiallergics  [7]
 A61P 27/16
·  Otologicals  [7]
P:190 A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)  [7]
 A61P 29/02
·  without antiinflammatory effect  [7]
P:180 A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics  [7]
 A61P 31/02
·  Local antiseptics  [7]
 A61P 31/04
·  Antibacterial agents  [7]
 A61P 31/06
·  ·  for tuberculosis  [7]
 A61P 31/08
·  ·  for leprosy  [7]
 A61P 31/10
·  Antimycotics  [7]
 A61P 31/12
·  Antivirals  [7]
 A61P 31/14
·  ·  for RNA viruses  [7]
 A61P 31/16
·  ·  ·  for influenza or rhinoviruses  [7]
 A61P 31/18
·  ·  ·  for HIV  [7]
 A61P 31/20
·  ·  for DNA viruses  [7]
 A61P 31/22
·  ·  ·  for herpes viruses  [7]
P:170 A61P 33/00
Antiparasitic agents  [7]
 A61P 33/02
·  Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis  [7]
 A61P 33/04
·  ·  Amoebicides  [7]
 A61P 33/06
·  ·  Antimalarials  [7]
 A61P 33/08
·  ·  for Pneumocystis carinii  [7]
 A61P 33/10
·  Anthelmintics  [7]
 A61P 33/12
·  ·  Schistosomicides  [7]
 A61P 33/14
·  Ectoparasiticides, e.g. scabicides  [7]
P:160 A61P 35/00
Antineoplastic agents  [7]
 A61P 35/02
·  specific for leukemia  [7]
 A61P 35/04
·  specific for metastasis  [7]
P:150 A61P 37/00
Drugs for immunological or allergic disorders  [7]
 A61P 37/02
·  Immunomodulators  [7]
 A61P 37/04
·  ·  Immunostimulants  [7]
 A61P 37/06
·  ·  Immunosuppressants, e.g. drugs for graft rejection  [7]
 A61P 37/08
·  Antiallergic agents (antiasthmatic agents A61P 11/06; ophthalmic antiallergics A61P 27/14)  [7]
P:200 A61P 39/00
General protective or antinoxious agents  [7]
 A61P 39/02
·  Antidotes  [7]
 A61P 39/04
·  Chelating agents  [7]
 A61P 39/06
·  Free radical scavengers or antioxidants  [7]
P:10 A61P 41/00
Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution  [7]
P:210 A61P 43/00
Drugs for specific purposes, not provided for in groups A61P 1/00-A61P 41/00  [7]